<DOC>
	<DOC>NCT02494778</DOC>
	<brief_summary>The purpose of the study is to collect and assess long term data on the safety, tolerability, and efficacy of pridopidine in patients with Huntington's disease (HD).</brief_summary>
	<brief_title>A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>PrideHD completion within the last 6 months, including 2week followup period Weight â‰¥50 kg at screening Women of childbearing potential or male participants: Adequate contraception and birth control Good general health other criteria apply, please contact the investigator for more information Similar baseline criteria for ECG, vital signs, cardiovascular system, and renal function to PRIDEHD; Similar concomitant medication restrictions to PRIDEHD. other criteria apply, please contact the investigator for more information</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>